Análisis de la acción Iris Acquisition II Corp (IRAB)

Análisis de IA of Iris Acquisition II Corp (IRAB)

Mantener

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.

Métricas de valoración

El PER previsto actual de Iris Acquisition II Corp (IRAB) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E

P/E actual

0.00

EV/EBITDA previsto

Media 5A EV/EBITDA

EV/EBITDA actual

0.00

Precio/ventas previsto

Media 5A P/S

P/S actual

0.00

Ballenas con IRAB en cartera

C

Cable Car Capital LLC

+ Con en carteraIRAB

-4.58%

Rentabilidad a 3 meses

A

Aristeia Capital, LLC

+ Con en carteraIRAB

-5.59%

Rentabilidad a 3 meses

Preguntas frecuentes sobre IRAB, respondidas por Alphio AI

Iris Acquisition Corp II, located in Dubai, the United Arab Emirates, is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It operates in the Financials sector.

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.